Used in pharmaceutical research as a key intermediate in the synthesis of nicotinic acetylcholine receptor (nAChR) modulators. It is particularly valuable in developing compounds targeting neurological disorders such as Alzheimer's disease, Parkinson's disease, and schizophrenia. Its structural features allow for high selectivity and binding affinity to specific receptor subtypes, making it suitable for optimizing drug candidates. Also employed in the development of novel antidepressants and cognitive enhancers due to its ability to cross the blood-brain barrier effectively.